BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

CNS Response CEO George Carpenter to Present at the Rodman & Renshaw 13th Annual Healthcare Conference


9/1/2011 8:53:58 AM

ALISO VIEJO, CA--(Marketwire - September 01, 2011) - CNS Response, Inc. (OTCBB: CNSO) today announced that CEO George Carpenter will be presenting at the Rodman & Renshaw 13th Annual Healthcare Conference to be held on September 11 - 13, 2011, at the Waldorf Astoria Hotel in New York, NY. Mr. Carpenter's presentation is scheduled for Tuesday, September 13 at 4:30 p.m. Eastern in the hotel's Starlight Center.

One-on-one meetings with Mr. Carpenter can be scheduled by conference attendees through the Rodman & Renshaw conference website, http://www.rodmanandrenshaw.com.

To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of the CNS Response website at http://www.cnsresponse.com, or at http://www.wsw.com/webcast/rrshq20/cnso. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads. An archived replay will be available for 90 days beginning 24 hours after the live presentation.

About CNS Response
CNS Response provides reference data and analytic tools for clinicians and researchers in psychiatry. While treatment for mental disorders has doubled in the last 20 years, it is estimated that 17 million Americans have failed two or more medication therapies for their mental disorder. The company recently launched the Psychiatric EEG Evaluation Registry, or PEER Online™, a new registry and reporting platform that allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through an EEG. PEER Online builds on the company's original physician-developed database, Referenced-EEG® (rEEG®). Avoiding trial and error pharmacotherapy, the dominant approach for psychiatric treatment, is the objective of PEER Online™.

To read more about the benefits of this patented technology for patients, physicians and payers, please visit www.cnsresponse.com. Medical professionals interested in learning more can contact CNS Response at PEERinfo@cnsresponse.com.


Investor Relations:
Marty Tullio
Managing Partner
McCloud Communications, LLC
949.553.9748
Email Contact

Media Relations:
Joyce Johannson
Johannson Communications
612.927.4543 (office)
612.845.3080 (cell)
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES